ENFN logo

Enfusion, Inc. (ENFN) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $ ist Enfusion, Inc. (ENFN) ein Technology-Unternehmen mit einer Bewertung von 0.

Zuletzt analysiert: 17. März 2026

Enfusion, Inc. (ENFN) Technologieprofil & Wettbewerbsposition

CEOOleg Movchan
Mitarbeiter1143
HauptsitzChicago, US
IPO-Jahr2021

Enfusion, Inc. delivers cloud-native SaaS solutions for investment management, offering a unified platform for portfolio management, order execution, and accounting. Targeting hedge funds, asset managers, and fund administrators, Enfusion streamlines workflows and enhances operational efficiency in a competitive fintech landscape. The company operates globally, serving clients across multiple regions.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

Enfusion, Inc. presents a compelling investment case driven by its integrated SaaS platform and strong position within the investment management technology sector. The company's unified platform addresses the growing demand for streamlined workflows and real-time data insights, driving adoption among hedge funds, asset managers, and fund administrators. With a gross margin of 68.6%, Enfusion demonstrates pricing power and efficient service delivery. Growth catalysts include expanding its global footprint and cross-selling additional modules to existing clients. However, the company's high P/E ratio of 660.32 suggests a premium valuation, and potential risks include increasing competition and the need to continually innovate its platform to meet evolving client needs. The company's beta of 0.93 indicates moderate volatility relative to the market.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $1.02 billion, reflecting investor confidence in Enfusion's growth potential.
  • High P/E ratio of 660.32, indicating a premium valuation based on future earnings expectations.
  • Gross margin of 68.6%, demonstrating efficient cost management and pricing power.
  • Beta of 0.93, suggesting moderate volatility compared to the overall market.
  • Profit margin of 1.5%, indicating room for improvement in operational efficiency and profitability.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Unified, cloud-native platform
  • Strong industry expertise
  • Recurring revenue model
  • Scalable architecture

Schwaechen

  • High P/E ratio
  • Limited profitability
  • Dependence on key personnel
  • Relatively short operating history

Katalysatoren

  • Upcoming: Launch of new modules and features to enhance platform functionality.
  • Ongoing: Expansion into new geographic markets, particularly in the Asia Pacific region.
  • Ongoing: Increasing adoption of SaaS solutions by investment management firms.
  • Ongoing: Strategic partnerships and collaborations to expand product offerings.

Risiken

  • Potential: Increasing competition from established players and new entrants.
  • Potential: Evolving regulatory landscape and compliance requirements.
  • Potential: Cybersecurity threats and data breaches.
  • Potential: Economic downturn and reduced investment activity.
  • Ongoing: Dependence on key personnel and the ability to attract and retain talent.

Wachstumschancen

  • Expanding Global Footprint: Enfusion has the opportunity to further expand its global presence, particularly in the Asia Pacific region. The increasing sophistication of investment management firms in these markets creates a demand for advanced technology solutions. By establishing strategic partnerships and tailoring its platform to local market needs, Enfusion can capture a larger share of the global market. This expansion could contribute significantly to revenue growth over the next 3-5 years.
  • Cross-Selling Additional Modules: Enfusion can drive revenue growth by cross-selling additional modules to its existing client base. The company's unified platform allows for seamless integration of new functionalities, making it easier for clients to adopt additional services. By focusing on demonstrating the value of these modules and offering bundled pricing options, Enfusion can increase its revenue per client and strengthen its customer relationships. This strategy can yield incremental revenue growth within the next 1-2 years.
  • Enhancing Data Analytics Capabilities: Enfusion can further enhance its data analytics capabilities to provide clients with deeper insights into their portfolios and investment strategies. By integrating advanced analytics tools and machine learning algorithms into its platform, Enfusion can help clients identify trends, optimize portfolio performance, and manage risk more effectively. This enhancement can attract new clients and increase the stickiness of its existing client base. The timeline for significant advancements in this area is approximately 2-3 years.
  • Developing Solutions for New Asset Classes: Enfusion can expand its addressable market by developing solutions for new asset classes, such as digital assets and private equity. These asset classes are experiencing rapid growth, and investment management firms are seeking technology solutions to manage these investments effectively. By adapting its platform to support these new asset classes, Enfusion can tap into a new revenue stream and solidify its position as a leading provider of investment management technology. This expansion could begin to show results within the next 2-4 years.
  • Strategic Acquisitions: Enfusion can pursue strategic acquisitions to expand its product offerings and geographic reach. By acquiring complementary technology companies or firms with a strong presence in key markets, Enfusion can accelerate its growth and enhance its competitive position. These acquisitions can provide access to new technologies, talent, and client relationships, driving long-term value creation. The timing and impact of acquisitions are difficult to predict, but they represent a significant growth opportunity.

Chancen

  • Expanding global footprint
  • Cross-selling additional modules
  • Enhancing data analytics capabilities
  • Developing solutions for new asset classes

Risiken

  • Increasing competition
  • Evolving regulatory landscape
  • Cybersecurity risks
  • Economic downturn

Wettbewerbsvorteile

  • Integrated Platform: Enfusion's unified platform provides a seamless experience for clients, creating a strong competitive advantage.
  • Cloud-Native Architecture: The cloud-native architecture offers scalability, flexibility, and cost-effectiveness.
  • Industry Expertise: Enfusion's deep understanding of the investment management industry allows it to develop tailored solutions.
  • High Switching Costs: The complexity of migrating investment management systems creates high switching costs for clients.

Ueber ENFN

Enfusion, Inc., incorporated in 2021 and headquartered in Chicago, Illinois, provides software-as-a-service (SaaS) solutions tailored for the investment management industry. The company's core offering is a unified, cloud-native platform that integrates portfolio management, order and execution management, and accounting functionalities. This platform is designed to streamline workflows, enhance operational efficiency, and provide real-time data insights for investment professionals. Enfusion's solutions cater to a diverse range of clients, including hedge funds, asset managers, and fund administrators. Enfusion's portfolio management system generates a real-time investment book of record, offering valuation and risk tools that enable users to analyze aggregated or decomposed portfolio data. The order and execution management system facilitates electronic communication of trade orders across various asset classes, managing trade orders, and enforcing trading regulations. The accounting/general ledger system provides a real-time accounting book of record for financial officers, accountants, and operations teams. Enfusion also offers an analytics system that enables users to analyze portfolios through time horizons and automate customized visualized reports. The company's technology-powered and managed services further enhance its value proposition. With a global presence spanning the United States, Europe, the Middle East, Africa, and the Asia Pacific, Enfusion serves a broad client base. The company's integrated platform and comprehensive suite of services position it as a key player in the competitive fintech landscape, addressing the evolving needs of investment management firms.

Was das Unternehmen tut

  • Provides a unified, cloud-native SaaS platform for investment management.
  • Offers portfolio management system with real-time investment book of record.
  • Delivers order and execution management system for electronic trade order communication.
  • Provides accounting/general ledger system for financial officers and operations teams.
  • Offers Enfusion analytics system for portfolio analysis and customized reporting.
  • Provides technology-powered and managed services to enhance its platform.

Geschaeftsmodell

  • Software-as-a-Service (SaaS): Enfusion generates revenue through subscription fees for its platform and modules.
  • Recurring Revenue: The SaaS model provides a recurring revenue stream, ensuring stable and predictable income.
  • Value-Added Services: Enfusion offers managed services and consulting to supplement its platform and generate additional revenue.

Branchenkontext

Enfusion operates within the application software segment of the technology sector. The investment management industry is increasingly adopting SaaS solutions to streamline operations, enhance data analytics, and improve decision-making. The competitive landscape includes companies like AVPT, CLBT, ETWO, MKFG, and ML, each offering various solutions for investment management firms. Enfusion differentiates itself with its unified platform approach, integrating portfolio management, order execution, and accounting into a single system. The industry is experiencing growth driven by increasing regulatory complexity, the need for real-time data insights, and the demand for cost-effective solutions.

Wichtige Kunden

  • Hedge Funds: Enfusion serves hedge funds of various sizes and investment strategies.
  • Asset Managers: The company caters to traditional asset managers, providing solutions for portfolio management and reporting.
  • Fund Administrators: Enfusion supports fund administrators with accounting and operational solutions.
KI-Zuversicht: 71% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

Enfusion, Inc. (ENFN) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ENFN.

Kursziele

Wall-Street-Kurszielanalyse fuer ENFN.

MoonshotScore

0/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von ENFN auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Oleg Movchan

CEO

Oleg Movchan is the CEO of Enfusion, Inc., leading a team of 1143 employees. His background includes extensive experience in the technology and financial services industries. Prior to joining Enfusion, Oleg held leadership positions at various software companies, where he focused on developing and implementing innovative solutions for the financial sector. He has a proven track record of driving growth and improving operational efficiency. Oleg's expertise lies in building and scaling technology businesses, with a focus on delivering value to clients.

Erfolgsbilanz: Since becoming CEO of Enfusion, Oleg Movchan has overseen the company's continued growth and expansion. He has focused on strengthening the company's product offerings, expanding its global presence, and enhancing its customer relationships. Under his leadership, Enfusion has achieved significant milestones, including the successful launch of new modules and the expansion into new markets. Oleg's strategic decisions have contributed to the company's strong financial performance and its position as a leading provider of investment management technology.

Was Anleger ueber Enfusion, Inc. (ENFN) wissen wollen

What are the key factors to evaluate for ENFN?

Evaluating ENFN involves reviewing fundamentals, analyst consensus, and risk factors. Key strength: Unified, cloud-native platform. Primary risk to monitor: Potential: Increasing competition from established players and new entrants.. This is not financial advice.

How frequently does ENFN data refresh on this page?

ENFN prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ENFN's recent stock price performance?

Recent price movement in Enfusion, Inc. (ENFN) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Unified, cloud-native platform. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider ENFN overvalued or undervalued right now?

Determining whether Enfusion, Inc. (ENFN) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying ENFN?

Before investing in Enfusion, Inc. (ENFN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding ENFN to a portfolio?

Potential reasons to consider Enfusion, Inc. (ENFN) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Unified, cloud-native platform. Additionally: Strong industry expertise. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of ENFN?

Yes, most major brokerages offer fractional shares of Enfusion, Inc. (ENFN) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track ENFN's earnings and financial reports?

Enfusion, Inc. (ENFN) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ENFN earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Financial data is based on publicly available information.
  • AI analysis is pending and may provide additional insights.
  • The competitive landscape is subject to change.
Datenquellen

Popular Stocks